Showing results (201-210 of 226) with videos related to
Sort By:
Pageof 23
Molecular Therapy. Nucleic Acids|May 29, 2020
lncRNA LINC00665 Stabilized by TAF15 Impeded the Malignant Biological Behaviors of Glioma Cells via STAU1-Mediated mRNA DegradationXuelei Ruan, Jian Zheng, Xiaobai Liu, et al.Journal of Experimental & Clinical Cancer Research : CR|January 30, 2019
FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HGShuo Cao, Jian Zheng, Xiaobai Liu, et al.World Journal of Urology|December 29, 2022
Comparison of minimally invasive versus open pelvic organ-preserving radical cystectomy in female patients with bladder cancer: a multicenter propensity score matching analysisWenlong Zhong, Jibiao Li, Libo Liu, et al.Acta Pharmaceutica Sinica. B|June 3, 2024
Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosisHongliang Qiu, Sihui Huang, Yuting Liu, et al.International Journal of Biological Macromolecules|November 28, 2023
m5C modification of LINC00324 promotes angiogenesis in glioma through CBX3/VEGFR2 pathwayAini Pan, Yixue Xue, Xuelei Ruan, et al.Molecular Therapy. Nucleic Acids|May 8, 2026
Retraction Notice to: lncRNA LINC00665 Stabilized by TAF15 Impeded the Malignant Biological Behaviors of Glioma Cells via STAU1-Mediated mRNA DegradationXuelei Ruan, Jian Zheng, Xiaobai Liu, et al.Cancer Science|January 17, 2020
Transcription factor AP-4 (TFAP4)-upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA-520f-3p feedback loopYipeng Wang, Chunqing Yang, Xiaobai Liu, et al.Journal of Medical Genetics|September 17, 2025
Heterozygous TBX2 frameshift variants cause a novel syndromic hearing loss with incompletely penetrant nystagmusWan Hua, Yanfei Wang, Xiang Li, et al.Bio-Protocol|April 2, 2026
A Novel Sequencing Method for Quantification of ZIKV RNA in Individual CellsMin Hao, Yisong Wang, Dianyi Du, et al.Cellular Signalling|June 3, 2026
Drug repurposing for pancreatic cancer: Lomitapide Mesylate as a potent HK2 inhibitor discovered via virtual screeningXin Tan, Ying Zhang, Miao Liu, et al.Pageof 23